Anavex Life Sciences AVXL
NASDAQ AVXL
$1.89 -0.13 (-6.44%)
At close: Oct 1, 2026 · 4:00 PM EDT

Anavex Life Sciences (AVXL) Capital Expenditures (2013 - 2014)

Updated

Anavex Life Sciences' Capital Expenditures was $688.00 in fiscal Q4 2014 (quarter ended Sep 30, 2014).

Analysis

Anavex Life Sciences (AVXL) Capital Expenditures (2013 - 2014) Analysis & Trends

For FY2014 (ended Sep 30, 2014), Capital Expenditures at Anavex Life Sciences came in at $3,015.

  • Capital Expenditures shows a four-year compound annual growth rate of -2.3% (FY2010 to FY2014).
  • In earlier fiscal years, Capital Expenditures was $3,310 in FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.32 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 322.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -763.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 140.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 112.20 Mn
10 Anavex Life Sciences 187.25 Mn -292.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2014 688.00
Dec 31, 2013 2,327.00
API Access

Anavex Life Sciences Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=AVXL&period=max&api_key=YOUR_API_KEY